CD28-Autoantibodies in Melanoma patients - a new prognostic Marker?

被引:0
|
作者
Schmaltz, R. [1 ]
Madjidi, D. [1 ]
Preuss, K.-D. [2 ,3 ]
Mueller, C. S. [1 ]
Pfreundschuh, M. [2 ,3 ]
Graeber, S. [4 ]
Vogt, T. [1 ]
Pfoehler, C. [1 ]
机构
[1] Univ Klinikum Saarlandes, Klin Dermatol Venerol & Allergol, Homburg, Germany
[2] Univ Klinikum Saarlandes, Innere Med Klin 1, Homburg, Germany
[3] Univ Klinikum Saarlandes, Jose Carreras Zentrum Immun & Gentherapie, Homburg, Germany
[4] Univ Klinikum Saarlandes, Inst Med Biometrie Epidemiol & Med Informat, Homburg, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:138 / 138
页数:1
相关论文
共 50 条
  • [41] Rapidity of primary melanoma growth as a prognostic marker
    Grob, JJ
    Richard, MA
    Avril, MF
    Delaunay, M
    Gouvernet, J
    Wolkenstein, P
    Southeyrand, P
    Bonerandi, JJ
    Machet, L
    Guillaume, JC
    Chevrant-Breton, J
    Vilmer, C
    Aubin, F
    Guillot, B
    Beylot-Barry, M
    Lok, C
    Raison-Peyron, N
    Chemaly, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (03) : 760 - 760
  • [42] The soluble form of RAGE as a prognostic marker in melanoma
    Wagner, N. B.
    Petzinger, D.
    Lichtenberger, R.
    Holland-Letz, T.
    Findeisen, P.
    Umansky, V
    Utikal, J.
    Enk, A. H.
    Gebhardt, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 904 - 905
  • [43] CD73 (NT5E) expression is a prognostic marker for primary melanoma patients and a potential predictive marker for anti-PD1 treatment
    Ramis, B. B.
    Reinhardt, J.
    Tueting, T.
    Hoelzel, M.
    Landsberg, J.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E95 - E96
  • [44] Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma
    Ross, DA
    Wilson, GD
    BRITISH JOURNAL OF SURGERY, 1998, 85 (01) : 46 - 51
  • [45] CD207 Expression Level is a New Prognostic Marker for Condyloma Acuminatum
    Zhang, Dong
    Qu, Yan
    Sui, Changlin
    Li, Meiling
    Yuan, Yanmei
    Wang, Ningning
    Ma, Weiyuan
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 1607 - 1613
  • [46] Autoantibodies against CD28 are associated with atopic diseases
    Neuber, K.
    Maehnss, B.
    Huebner, C.
    Gergely, H.
    Weichenthal, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (02): : 262 - 269
  • [47] Tumor infiltrating lymphocytes are a prognostic marker for survival in patients who develop melanoma metastases
    Wriston, C. C.
    Troxel, A. B.
    Shin, D. B.
    Schaffer, A.
    Rubin, A. I.
    Brauer, J. A.
    Ming, M. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S61 - S61
  • [48] Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma
    Tanabe, Kenichi
    Amoh, Yasuyuki
    Kanoh, Maho
    Takasu, Hiroshi
    Sakai, Naohiko
    Sato, Yuichi
    Katsuoka, Kensei
    EUROPEAN JOURNAL OF DERMATOLOGY, 2010, 20 (03) : 283 - 288
  • [49] Neutrophil to Lymphocyte ratio (NLR): A prognostic marker in melanoma patients receiving immunotherapy.
    O'Dwyer, Richard Thomas
    Dennehy, Colum
    Sui, Jane Sze Yin
    Kelly, Catherine Margaret
    Calvert, Paula
    McCaffrey, John
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] POLYMERASE CHAIN-REACTION DETECTION OF CIRCULATING MELANOCYTES AS A PROGNOSTIC MARKER IN PATIENTS WITH MELANOMA
    BATTAYANI, Z
    GROB, JJ
    XERRI, L
    NOE, C
    ZAROUR, H
    HOUVAENEGHEL, G
    DELPERO, JR
    BIRMBAUM, D
    HASSOUN, J
    BONERANDI, JJ
    ARCHIVES OF DERMATOLOGY, 1995, 131 (04) : 443 - 447